Analysts Set Simulations Plus, Inc. (NASDAQ:SLP) Price Target at $25.00
by Kim Johansen · The Markets DailyShares of Simulations Plus, Inc. (NASDAQ:SLP – Get Free Report) have been given an average recommendation of “Hold” by the ten analysts that are presently covering the firm, MarketBeat reports. One analyst has rated the stock with a sell rating, six have given a hold rating and three have assigned a buy rating to the company. The average 1 year price objective among analysts that have covered the stock in the last year is $25.00.
A number of analysts recently weighed in on the stock. Zacks Research lowered shares of Simulations Plus from a “strong-buy” rating to a “hold” rating in a report on Monday, February 2nd. BTIG Research downgraded shares of Simulations Plus from a “buy” rating to a “neutral” rating in a report on Thursday, December 18th. Wall Street Zen lowered shares of Simulations Plus from a “buy” rating to a “hold” rating in a research report on Saturday. TD Cowen restated a “hold” rating on shares of Simulations Plus in a research report on Thursday, January 8th. Finally, Citigroup restated a “market perform” rating on shares of Simulations Plus in a research report on Tuesday, January 6th.
View Our Latest Stock Analysis on SLP
Simulations Plus Stock Performance
Shares of SLP opened at $11.99 on Thursday. Simulations Plus has a 52-week low of $11.09 and a 52-week high of $36.45. The stock’s 50-day simple moving average is $13.06 and its 200 day simple moving average is $16.06. The stock has a market capitalization of $241.60 million, a price-to-earnings ratio of -3.75 and a beta of 1.19.
Simulations Plus (NASDAQ:SLP – Get Free Report) last announced its quarterly earnings results on Thursday, January 8th. The technology company reported $0.13 earnings per share for the quarter, missing the consensus estimate of $0.18 by ($0.05). Simulations Plus had a negative net margin of 81.66% and a positive return on equity of 14.02%. The company had revenue of $18.42 million for the quarter, compared to the consensus estimate of $18.05 million. During the same quarter in the prior year, the company earned $0.17 earnings per share. On average, research analysts forecast that Simulations Plus will post 1.09 earnings per share for the current fiscal year.
Hedge Funds Weigh In On Simulations Plus
Several institutional investors and hedge funds have recently made changes to their positions in SLP. Raymond James Financial Inc. bought a new stake in Simulations Plus in the second quarter worth $25,000. Quarry LP bought a new position in shares of Simulations Plus during the third quarter valued at about $28,000. CWM LLC grew its stake in shares of Simulations Plus by 3,729.1% during the third quarter. CWM LLC now owns 2,106 shares of the technology company’s stock valued at $32,000 after buying an additional 2,051 shares during the last quarter. Farther Finance Advisors LLC purchased a new position in shares of Simulations Plus in the third quarter worth about $40,000. Finally, Caitong International Asset Management Co. Ltd increased its holdings in shares of Simulations Plus by 343.0% in the fourth quarter. Caitong International Asset Management Co. Ltd now owns 3,983 shares of the technology company’s stock worth $73,000 after buying an additional 3,084 shares during the period. Institutional investors own 78.08% of the company’s stock.
Simulations Plus Company Profile
Simulations Plus, Inc (NASDAQ: SLP) specializes in advanced modeling and simulation software tailored to the pharmaceutical, biotechnology and chemical industries. The company’s flagship products include ADMET Predictor, a quantitative structure-activity relationship (QSAR) tool for predicting absorption, distribution, metabolism, excretion and toxicity properties, and GastroPlus, a physiologically based pharmacokinetic (PBPK) modeling platform for simulating drug absorption and pharmacokinetics.